Abstract

Ultra-small gold nanoparticles (Au-NPs) “≤ 10 nm diameters” have potent biomedical applications. Hence, the present study aimed to greenly synthesize ultra-small gold nanoparticles using Egyptian propolis extract. Different biological activities, in vivo bio-distribution and acute toxicity study were assessed. Results revealed that, Egyptian propolis extract can successfully synthesize the highly pure and stable ultra-small Au-NPs with average diameter 7.8 nm. In vitro antimicrobial and antimycobacterial activities revealed the powerful effect of the prepared Au-NPs. Moreover, the cytotoxic effect on human cancer cell lines revealed the potent inhibition of the cancer cells’ proliferation with high reactive oxygen species-mediated apoptosis induction. In vivo bio-distribution and acute toxicity studies were performed (10 and 100 mg/kg doses) in male albino rats. The ultra-small Au-NPs showed low or no toxicity upon using the Au-NPs low dose. The mean area accumulation (%) of the Au-NPs was higher in the liver, kidney, and brain tissues (4.41, 2.96, and 0.3 times, respectively) treated with high Au-NPs dosage compared to those treated with the low dose. Surprisingly, Au-NP accumulation in brain tissue was observed in the glial cells only. Accordingly, the low dose (10 mg/kg) of Au-NPs can be used safely in a variety of biomedical applications.

Details

Title
In vivo bio-distribution and acute toxicity evaluation of greenly synthesized ultra-small gold nanoparticles with different biological activities
Author
Aljohani, Faizah S 1 ; Hamed, Moaaz T 2 ; Bakr, Basant A 3 ; Shahin, Yahya H 4 ; Abu-Serie, Marwa M 5 ; Awaad, Ashraf K 6 ; El-Kady, Hadir 4 ; Elwakil, Bassma H 4 

 Taibah University, Chemistry Department, Faculty of Science, Medina, Saudi Arabia (GRID:grid.412892.4) (ISNI:0000 0004 1754 9358) 
 Alexandria University, Botany & Microbiology Department, Faculty of Science, Alexandria, Egypt (GRID:grid.7155.6) (ISNI:0000 0001 2260 6941) 
 Alexandria University, Zoology Department, Faculty of Science, Alexandria, Egypt (GRID:grid.7155.6) (ISNI:0000 0001 2260 6941) 
 Pharos University in Alexandria, Medical Laboratory Technology Department, Faculty of Applied Health Sciences Technology, Alexandria, Egypt (GRID:grid.442603.7) (ISNI:0000 0004 0377 4159) 
 City of Scientific Research and Technological Applications (SRTA-City), Medical Biotechnology Department, Genetic Engineering and Biotechnology Research Institute, New Borg El Arab, Egypt (GRID:grid.420020.4) (ISNI:0000 0004 0483 2576) 
 Alexandria University, Biochemistry and Molecular Biology Department, Center of Excellence for Research in Regenerative Medicine and Applications (CERRMA), Faculty of Medicine, Alexandria, Egypt (GRID:grid.7155.6) (ISNI:0000 0001 2260 6941) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2650317322
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.